vs
Protalix BioTherapeutics, Inc.（PLX）与PodcastOne, Inc.（PODC）财务数据对比。点击上方公司名可切换其他公司
PodcastOne, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.7倍（$15.9M vs $9.1M），PodcastOne, Inc.净利率更高（-1.0% vs -60.3%，领先59.4%），PodcastOne, Inc.同比增速更快（24.8% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $489.0K），过去两年PodcastOne, Inc.的营收复合增速更高（16.4% vs -6.7%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
PodcastOne是一家知名音频娱乐企业，专注于播客制作、分发与变现业务，旗下拥有覆盖真实罪案、喜剧、新闻、体育、生活方式等品类的海量原创及授权播客内容，服务全球听众，同时为创作者和品牌提供广告解决方案。
PLX vs PODC — 直观对比
营收规模更大
PODC
是对方的1.7倍
$9.1M
营收增速更快
PODC
高出74.7%
-49.9%
净利率更高
PODC
高出59.4%
-60.3%
自由现金流更多
PLX
多$1.1M
$489.0K
两年增速更快
PODC
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $15.9M |
| 净利润 | $-5.5M | $-154.0K |
| 毛利率 | 49.4% | 16.5% |
| 营业利润率 | -51.1% | -1.0% |
| 净利率 | -60.3% | -1.0% |
| 营收同比 | -49.9% | 24.8% |
| 净利润同比 | -184.8% | 90.3% |
| 每股收益（稀释后） | $-0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXPODC
| Q4 25 | $9.1M | $15.9M | ||
| Q3 25 | $17.9M | $15.2M | ||
| Q2 25 | $15.7M | $15.0M | ||
| Q1 25 | $10.1M | $14.1M | ||
| Q4 24 | $18.2M | $12.7M | ||
| Q3 24 | $18.0M | $12.2M | ||
| Q2 24 | $13.5M | $13.2M | ||
| Q1 24 | — | $11.7M |
净利润PLXPODC
| Q4 25 | $-5.5M | $-154.0K | ||
| Q3 25 | $2.4M | $-975.0K | ||
| Q2 25 | $164.0K | $-1.1M | ||
| Q1 25 | $-3.6M | $-1.8M | ||
| Q4 24 | $6.5M | $-1.6M | ||
| Q3 24 | $3.2M | $-1.7M | ||
| Q2 24 | $-2.2M | $-1.4M | ||
| Q1 24 | — | $-1.0M |
毛利率PLXPODC
| Q4 25 | 49.4% | 16.5% | ||
| Q3 25 | 53.4% | 10.6% | ||
| Q2 25 | 62.5% | 9.6% | ||
| Q1 25 | 19.1% | 10.9% | ||
| Q4 24 | 78.7% | 5.7% | ||
| Q3 24 | 53.4% | 8.3% | ||
| Q2 24 | 29.8% | 11.0% | ||
| Q1 24 | — | 8.9% |
营业利润率PLXPODC
| Q4 25 | -51.1% | -1.0% | ||
| Q3 25 | 11.9% | -6.4% | ||
| Q2 25 | 7.5% | -7.0% | ||
| Q1 25 | -41.0% | -13.0% | ||
| Q4 24 | 39.6% | -12.4% | ||
| Q3 24 | 22.2% | -13.6% | ||
| Q2 24 | -18.0% | -10.4% | ||
| Q1 24 | — | -10.1% |
净利率PLXPODC
| Q4 25 | -60.3% | -1.0% | ||
| Q3 25 | 13.2% | -6.4% | ||
| Q2 25 | 1.0% | -7.0% | ||
| Q1 25 | -35.8% | -13.1% | ||
| Q4 24 | 35.6% | -12.5% | ||
| Q3 24 | 18.0% | -13.7% | ||
| Q2 24 | -16.4% | -10.4% | ||
| Q1 24 | — | -9.0% |
每股收益（稀释后）PLXPODC
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.03 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $3.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $15.8M |
| 总资产 | $82.3M | $24.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXPODC
| Q4 25 | $14.7M | $3.4M | ||
| Q3 25 | $13.6M | $2.7M | ||
| Q2 25 | $17.9M | $1.9M | ||
| Q1 25 | $19.5M | $1.1M | ||
| Q4 24 | $19.8M | $572.0K | ||
| Q3 24 | $27.4M | $1.4M | ||
| Q2 24 | $23.4M | $891.0K | ||
| Q1 24 | — | $1.4M |
股东权益PLXPODC
| Q4 25 | $48.2M | $15.8M | ||
| Q3 25 | $52.9M | $14.7M | ||
| Q2 25 | $49.9M | $14.7M | ||
| Q1 25 | $45.2M | $15.1M | ||
| Q4 24 | $43.2M | $15.0M | ||
| Q3 24 | $32.4M | $15.5M | ||
| Q2 24 | $28.6M | $15.7M | ||
| Q1 24 | — | $16.3M |
总资产PLXPODC
| Q4 25 | $82.3M | $24.7M | ||
| Q3 25 | $82.3M | $22.6M | ||
| Q2 25 | $78.5M | $22.3M | ||
| Q1 25 | $73.9M | $20.8M | ||
| Q4 24 | $73.4M | $20.6M | ||
| Q3 24 | $61.6M | $23.1M | ||
| Q2 24 | $91.5M | $24.0M | ||
| Q1 24 | — | $24.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $579.0K |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $489.0K |
| 自由现金流率自由现金流/营收 | 17.8% | 3.1% |
| 资本支出强度资本支出/营收 | 4.4% | 0.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | — |
8季度趋势，按日历期对齐
经营现金流PLXPODC
| Q4 25 | $2.0M | $579.0K | ||
| Q3 25 | $-3.7M | $877.0K | ||
| Q2 25 | $-5.2M | $903.0K | ||
| Q1 25 | $-5.1M | $506.0K | ||
| Q4 24 | $4.0M | $-763.0K | ||
| Q3 24 | $4.1M | $525.0K | ||
| Q2 24 | $-3.6M | $-480.0K | ||
| Q1 24 | — | — |
自由现金流PLXPODC
| Q4 25 | $1.6M | $489.0K | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-5.7M | $791.0K | ||
| Q1 25 | $-5.4M | $505.0K | ||
| Q4 24 | $3.6M | $-783.0K | ||
| Q3 24 | $4.0M | $464.0K | ||
| Q2 24 | $-3.8M | $-554.0K | ||
| Q1 24 | — | — |
自由现金流率PLXPODC
| Q4 25 | 17.8% | 3.1% | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -36.2% | 5.3% | ||
| Q1 25 | -53.0% | 3.6% | ||
| Q4 24 | 19.6% | -6.2% | ||
| Q3 24 | 22.4% | 3.8% | ||
| Q2 24 | -28.1% | -4.2% | ||
| Q1 24 | — | — |
资本支出强度PLXPODC
| Q4 25 | 4.4% | 0.6% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 2.8% | 0.7% | ||
| Q1 25 | 3.0% | 0.0% | ||
| Q4 24 | 2.3% | 0.2% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 1.3% | 0.6% | ||
| Q1 24 | — | — |
现金转化率PLXPODC
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
PODC
| Other | $9.0M | 56% |
| Barter | $6.9M | 44% |
